BR9812588A - Métodos e composições farmacêuticas para liberação oral de iodo molecular - Google Patents

Métodos e composições farmacêuticas para liberação oral de iodo molecular

Info

Publication number
BR9812588A
BR9812588A BR9812588-5A BR9812588A BR9812588A BR 9812588 A BR9812588 A BR 9812588A BR 9812588 A BR9812588 A BR 9812588A BR 9812588 A BR9812588 A BR 9812588A
Authority
BR
Brazil
Prior art keywords
iodine
compositions
molecular iodine
pharmaceutical methods
mammal
Prior art date
Application number
BR9812588-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Yongjun Duan
John Hickey
Rick Panicucci
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of BR9812588A publication Critical patent/BR9812588A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9812588-5A 1997-10-29 1998-10-27 Métodos e composições farmacêuticas para liberação oral de iodo molecular BR9812588A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine
PCT/US1998/022720 WO1999021567A1 (en) 1997-10-29 1998-10-27 Pharmaceutical compositions for oral administration of molecular iodine

Publications (1)

Publication Number Publication Date
BR9812588A true BR9812588A (pt) 2000-07-25

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812588-5A BR9812588A (pt) 1997-10-29 1998-10-27 Métodos e composições farmacêuticas para liberação oral de iodo molecular

Country Status (17)

Country Link
US (1) US5885592A (enExample)
EP (1) EP1024815B1 (enExample)
JP (1) JP4187410B2 (enExample)
KR (1) KR100412219B1 (enExample)
CN (1) CN1150904C (enExample)
AT (1) ATE231725T1 (enExample)
AU (1) AU750627B2 (enExample)
BR (1) BR9812588A (enExample)
CA (1) CA2301503C (enExample)
DE (1) DE69811105T2 (enExample)
DK (1) DK1024815T3 (enExample)
ES (1) ES2191973T3 (enExample)
IL (1) IL134778A0 (enExample)
NO (1) NO20001673L (enExample)
PT (1) PT1024815E (enExample)
RU (1) RU2213564C2 (enExample)
WO (1) WO1999021567A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
AU1693099A (en) * 1998-01-06 1999-07-26 Fujisawa Pharmaceutical Co., Ltd. Solid preparation of iodophor and its manufacturing methods
JP2002518351A (ja) * 1998-06-19 2002-06-25 オキシバイオ・インコーポレイテッド 抗感染および避妊特性を有する医療装置
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
ATE320831T1 (de) * 2000-10-06 2006-04-15 Dmg Italia Srl Immunotrophische preparation zur behandlung von tonsilläre hypertrophie
RU2201229C1 (ru) * 2002-03-26 2003-03-27 Миронов Владимир Андреевич Способ оздоровления организма
JP4586018B2 (ja) * 2003-06-20 2010-11-24 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 猫における甲状腺機能亢進症を予防する方法及び限定されたヨウ素を含む組成物
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
RU2432941C2 (ru) * 2006-01-26 2011-11-10 Хилл'С Пет Ньютришн, Инк. Способы и композиции для лечения гипертиреоза у кошачьих
AU2007249806B2 (en) * 2006-05-12 2011-07-07 Hill's Pet Nutrition, Inc. Compositions and methods for preventing or treating chronic renal failure in felines with hyperthyroidism
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
CN101511205A (zh) * 2006-07-03 2009-08-19 希尔氏宠物营养品公司 用于在甲状腺机能亢进的猫科动物中预防或治疗心血管疾病的组合物和方法
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
KR20140033123A (ko) * 2011-05-16 2014-03-17 쇼칸 사비르하노비치 베갈리예프 항바이러스성, 항궤양 및 면역 자극 작용을 가지고, 르네상스라는 이름을 가지는 의학 조제물
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技（潍坊）有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
MX386702B (es) 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
WO2015153258A1 (en) 2014-03-31 2015-10-08 Iotech International, Llc Stable compositions of uncomplexed iodine and methods of use
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
AU2017300497A1 (en) 2016-07-21 2019-03-14 I2Pure Corp. Emollient topical disinfectants
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
WO2021198938A1 (ja) * 2020-03-31 2021-10-07 タイ ミン ファーマシューティカルズ ジェイエスシー 癌または子宮内膜症の患者における癌、子宮内膜症および疼痛の治療のためのジイソプロピルアミン化合物およびヨウ素
BR112023001995A2 (pt) 2020-08-13 2023-02-28 I2Pure Corp Composições de alta concentração de iodo molecular, formulações farmacêuticas, preparação e usos
WO2024201560A1 (en) * 2023-03-24 2024-10-03 Me.Link Co., Ltd. Iodine containing colloidal liquid composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Also Published As

Publication number Publication date
IL134778A0 (en) 2001-04-30
AU750627B2 (en) 2002-07-25
ES2191973T3 (es) 2003-09-16
PT1024815E (pt) 2003-06-30
EP1024815B1 (en) 2003-01-29
AU1122799A (en) 1999-05-17
DE69811105D1 (de) 2003-03-06
CA2301503A1 (en) 1999-05-06
RU2213564C2 (ru) 2003-10-10
DK1024815T3 (da) 2003-05-19
NO20001673L (no) 2000-05-24
ATE231725T1 (de) 2003-02-15
JP2003510243A (ja) 2003-03-18
KR20010030861A (ko) 2001-04-16
WO1999021567A1 (en) 1999-05-06
JP4187410B2 (ja) 2008-11-26
EP1024815A1 (en) 2000-08-09
CA2301503C (en) 2005-01-04
KR100412219B1 (ko) 2003-12-24
NO20001673D0 (no) 2000-03-31
CN1150904C (zh) 2004-05-26
CN1272789A (zh) 2000-11-08
DE69811105T2 (de) 2003-11-06
US5885592A (en) 1999-03-23

Similar Documents

Publication Publication Date Title
BR9812588A (pt) Métodos e composições farmacêuticas para liberação oral de iodo molecular
BRPI0207700B8 (pt) mistura de conjugados monodispersa, composição farmacêutica, e, uso de uma mistura substancialmente monodispersa de um conjugado de polipeptídeo de insulina-oligômero
IL208184A0 (en) Glp-1, and methods for treating diabetes
GR900100786A (el) Μέ?οδος παρασκευής μιας συν?έσεως η οποία να περιλαμβάνει ένα αναλγητικό με συνδιασμό με ένα παρεμποδιστή του Η1 ή Η2 ένα παρεμποδιστή αντλίας πρωτονίων ή ένα συνδυασμό αυτών.
DK0736004T3 (da) (2,4-disulfophenyl)-N-t-butylnitron, salte heraf og deres anvendelse som indfangningsmidler til farmaceutiske radikaler
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
BR9912356A (pt) Regime de tratamento para a administração de fenilacetilglutamina, fenilacetilisoglutamina, e/ou fenilacetato
WO2004043341A3 (en) Treatment for hemorrhagic shock
TR200000149T2 (tr) Serebral nörovasküler bozuklukların, müsküler baş ağrılarının önlenmesine yönelik kompozisyonlar
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
ID23441A (id) Komposisi yang mengandung fructan untuk pencegahan dan pengobatan kanker usus dan metode untuk pencegahan dan pengobatan kanker usus
GR3035231T3 (en) Use of sulodexide and of medicines containing it for the treatment of diabetic nephropathy.
CA2032475A1 (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
EP1007055A4 (en) METHODS OF ADMINISTERING AMIFOSTINE
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
BR9912609A (pt) Métodos de uso de um análogo de somatostatina
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
BR0017329A (pt) Formulção farmacêutica de um medicamento, uso de melatonina na fabricação de um medicamento, e, método para prevenção ou tratamento de sintomas de discinesia tardia em um paciente usanto tal medicamento
IL126159A (en) Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis
ATE344664T1 (de) Verbesserte methode zur eradikation von helicobacter pylori
EP0799618A3 (en) Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer
BR9809376A (pt) Pregnan-3-ol-20-onas
BR9907234A (pt) Polìmeros ligantes de gordura
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
BR0015329A (pt) Uso de óxido nìtrico para o tratamento de constrição das vias aéreas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1769 DE 20041130 POR TER SIDO APRESENTADA PAPELETA DE ESCLARECIMENTO.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements